Clinical trial
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron…
NCT00223964 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00223964 |
|---|---|
| Title | Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients |
| Official title | Randomized Double-Blind Parallel Group MultiCenter Study of the Efficacy of Two Doses of Ferrlecit® in Treatment of Iron Deficiency in Pediatric Hemodialysis Patients Receiving Epoetin. |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Ferrlecit (sodium ferric gluconate complex in sucrose injection) |
| Enrollment | 59 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2003 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 14, 2012 |
| Countries | Mexico, Poland, Russia, Serbia, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: